journal article·2023-10

Magnetic relaxation of various silica-based Mn-contrast agents in relationship with Mn2+ chemical transformations during fabrication

Olga Bochkova, Alexey Stepanov, Alsu Khazieva, Bulat Akhmadeev, Ildus Ismaev, Kirill Kholin, Irek Nizameev, Anastasiya Sapunova, Alexandra Voloshina, Artem Laskin, Daniil Smekalov, Maxim Tarasov, Yulia Budnikova, Asiya Mustafina

Publisher page

Abstract

The present work introduces the comparative analysis of different synthetic techniques for the facile one-pot synthesis of silica-based Mn-contrast agents. The growth of silica nanoparticles (SNs) via water-in-oil microemulsion and Stöber techniques occurring under ammonia-rich oxygenated conditions triggers hydrolytic and oxidative transformations of Mn2+ ions. However, high surface activity of in situ generated silica seeds facilitates a coordinative adsorption of both Mn2+ ions and products of their hydrolytic and oxidative transformations, which allows to optimize the synthetic techniques for distinguishing the longitudinal and transverse relaxivitiy r1 and r2 at 13.8 and 16.9 mM−1s−1 respectively. The amino acid-catalyzed growth of silica nanoparticles (SNs) allows their loading with Mn2+ ions with exclusion of their hydrolytic and oxidative transformations, although r1 and r2 are 2.9 and 12.6 mM−1s−1 correspondingly. The electrochemical behavior of the synthesized SNs confirm their efficient doping with Mn2+ even under the synthesis in the ammonia-rich conditions. The r1 and r2 values of the SNs synthesized under different conditions correlate with the symmetry and hydration numbers of the Mn2+ centers incorporated into the SNs. The low cytotoxicity and high hemocompatibility of the nanoparticles with the optimal r1(2)-values makes them promising for further in-vivo application.
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Lanthanide and Transition Metal Complexes · Nanoparticle-Based Drug Delivery · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Manganese(II) complexes as potential contrast agents for MRI10.1002/ejic.201101336 ↗
2. Manganese-enhanced MRI contrast agents: from small chelates to nanosized hybrids10.1002/ejic.201101163 ↗
3. Manganese complexes and manganese-based metal-organic frameworks as contrast agents in MRI and chemotherapeutics agents: applications and prospects10.1016/j.colsurfb.2022.112432 ↗
4. Recent progress on manganese-based nanostructures as responsive MRI contrast agents10.1002/chem.201802851 ↗
5. Recent progress in design and surface modification of manganese nanoparticles for MRI contrasting and therapy
6. Specific nanoarchitecture of silica nanoparticles codoped with the oppositely charged Mn2+ and Ru2+ complexes for dual paramagnetic-luminescent contrasting effects
7. Mn2+-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T1-weighted MRI10.1016/j.biomaterials.2013.08.009 ↗
8. Porous silica nanospheres with a confined mono(aquated) Mn(II)-Complex: a potential T1–T2 dual contrast agent for magnetic resonance imaging10.1021/acsabm.1c00937 ↗
9. Highly soluble multifunctional MnO nanoparticles for simultaneous optical and MRI imaging and cancer treatment using photodynamic therapy10.1039/c0jm01465f ↗
10. A hybrid silica nanoreactor framework for encapsulation of hollow manganese oxide nanoparticles of superior T1 magnetic resonance relaxivity10.1002/adfm.201501269 ↗
11. pH-Activatable MnO-based fluorescence and magnetic resonance bimodal nanoprobe for cancer imaging10.1002/adhm.201500908 ↗
12. Development of manganese-based nanoparticles as contrast probes for magnetic resonance imaging10.7150/thno.3448 ↗
13. Self-assembly of hyaluronic acid-mediated tumor-targeting theranostic nanoparticles10.1039/D0BM01855D ↗
14. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-Responsive MRI, ultrasonography and circumvention of MDR in cancer cells10.1016/j.biomaterials.2012.06.059 ↗
15. Synthesis of uniform hollow oxide nanoparticles through nanoscale acid etching10.1021/nl8019467 ↗
16. A new and facile method to prepare uniform hollow MnO/functionalized mSiO2 core/shell nanocomposites10.1021/nn200928r ↗
17. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of aipose-derived mesenchymal stem cells10.1021/ja1084095 ↗
18. A novel method for the preparation of Ru(bpy)32+-doped silica nanoparticles10.1016/j.matlet.2012.10.021 ↗
19. A comparative study of three different synthesis routes for hydrophilic fluorophore-doped silica nanoparticles10.1007/s11051-016-3334-0 ↗
20. Novel highly charged silica-coated Tb(III) nanoparticles with fluorescent properties sensitive to ion exchange and energy transfer processes in aqueous dispersions10.1021/la8032572 ↗
21. A Ni(III) complex stabilized by silica nanoparticles as an efficient nanoheterogeneous catalyst for oxidative C–H fluoroalkylation10.1039/C6DT01492E ↗
22. A novel method for the preparation of Ru(bpy)32+-doped silica nanoparticles10.1016/j.matlet.2012.10.021 ↗
23. Modified spin‐echo method for measuring nuclear relaxation times10.1063/1.1716296 ↗
24. How to perform accurate and reliable measurements of longitudinal and transverse relaxation times of MRI contrast media in aqueous solutions10.1002/cmmi.294 ↗
25. Relaxation processes in a system of two spins10.1103/PhysRev.99.559 ↗
26. Proton relaxation times in paramagnetic solutions. Effects of electron spin relaxation10.1063/1.1731684 ↗
27. Metal-amine coördination compounds. Manganese complexes with 2,2'-Bipyridine and 1,10-Phenanthroline10.1021/ja01610a098 ↗
28. Rates of formation and dissociation of complexes of manganese (II) with the ligands 1,10-phenanthroline, 2,2′-bipyridine, and 2,2′2 ″-terpyridine in anhydrous methanol10.1039/DT9730000399 ↗
29. Development of PEGylated KMnF3 nanoparticle as a T1-weighted contrast agent: chemical synthesis, in-vivo brain MR images, and account for high relaxivity10.1039/c3nr00721a ↗
30. NMR paramagnetic probing of polymer solutions using manganese(II) ions
31. A comparative study of three different synthesis routes for hydrophilic fluorophore-doped silica nanoparticles10.1007/s11051-016-3334-0 ↗
32. Synthetic tuning of CoII-doped silica nanoarchitecture towards electrochemical sensing ability10.3390/nano10071338 ↗
33. Water manganese exposure and children's intellectual function in Araihazar, Bangladesh10.1289/ehp.8030 ↗
34. Coordination complexes of manganese and their biomedical applications10.1002/slct.201601909 ↗
35. Tuning the emission properties of Ru(phen)32+ doped silica nanoparticles by changing the addition time of the dye during the Stöber process10.1021/la903995r ↗
36. Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents10.1002/cmmi.267 ↗
37. Interfacial uploading of luminescent hexamolybdenum cluster units onto amino-decorated silica nanoparticles as new design of nanomaterial for cellular imaging and photodynamic therapy10.1016/j.jcis.2018.12.013 ↗
38. Line widths in the paramagnetic resonance of transition ions in solution10.1021/j150555a022 ↗
39. Cellular imaging by green luminescence of Tb(III)-doped aminomodified silica nanoparticles10.1016/j.msec.2017.03.106 ↗
40. Luminescent silica nanoparticles for sensing acetylcholinesterase-catalyzed hydrolysis of acetylcholine10.1016/j.bios.2015.10.059 ↗
41. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths10.1097/01.rli.0000184756.66360.d3 ↗
42. Manganese-based MRI contrast agents: past, present, and future10.1016/j.tet.2011.07.076 ↗
43. Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy10.1155/2015/363278 ↗